Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Cope

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Clinical and Experimental Immunology|January 1, 1995
A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) productionK A Davies, A P Cope, J B Schofield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motifA E Herman, R M Tisch, S D Patel, et al.
Arthritis and Rheumatism|July 14, 1999
T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 allelesA P Cope, S D Patel, F Hall, et al.
Arthritis and Rheumatism|December 30, 2009
Functional autoantibodies against serpin E2 in rheumatoid arthritisH Maciejewska-Rodrigues, M Al-Shamisi, H Hemmatazad, et al.
The British Journal of Dermatology|December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient surveyS K Mahil, M Yates, S M Langan, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Clinical and Experimental Immunology|January 1, 1995
A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) productionK A Davies, A P Cope, J B Schofield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motifA E Herman, R M Tisch, S D Patel, et al.
Arthritis and Rheumatism|July 14, 1999
T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 allelesA P Cope, S D Patel, F Hall, et al.
Arthritis and Rheumatism|December 30, 2009
Functional autoantibodies against serpin E2 in rheumatoid arthritisH Maciejewska-Rodrigues, M Al-Shamisi, H Hemmatazad, et al.
The British Journal of Dermatology|December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient surveyS K Mahil, M Yates, S M Langan, et al.
Pageof 5